<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03964428</url>
  </required_header>
  <id_info>
    <org_study_id>fayoum dentistry</org_study_id>
    <nct_id>NCT03964428</nct_id>
  </id_info>
  <brief_title>Serum Ferritin and Hepicidin Concentration in Chronic Periodontitis Patients With T2DM</brief_title>
  <official_title>Decreased Ferritin And Increased Hepcidin Serum Levels In Periodontitis Patients With Diabetes Mellitus Type 2. Controlled Before-And-After Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fayoum University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fayoum University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      serum level of ferritin and hepicidin were evaluated in periodontitis patient with and
      without type 2 diabetes before and after non surgical periodontal treatment to clarify their
      in periodontal disease
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">January 30, 2019</completion_date>
  <primary_completion_date type="Actual">January 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ferritin concentration</measure>
    <time_frame>0-3 months</time_frame>
    <description>ng/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hepicidin concentration</measure>
    <time_frame>0-3 months</time_frame>
    <description>ng/ml</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Periodontitis</condition>
  <condition>Type2 Diabetes</condition>
  <arm_group>
    <arm_group_label>periodontitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>periodontitis with T2DM</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        participants were collected from the Outpatient Clinic, Department of Oral Medicine,
        Periodontology and Diagnosis, and the restorative clinic for the control subjects, Faculty
        of Oral and Dental Medicine, fayoum University
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with more than 30% of the sites had clinical attachment level (CAL) 3-4mm
             with T2DM

          -  systemically healthy patients with more than 30% of the sites had clinical attachment
             level (CAL) 3-4mm

          -  healthy subjects had clinically healthy gingiva with â‰¤ 3mm pocket probing depth (PPD),
             nearly zero plaque index (PI), gingival index (GI), zero CAL.

        Exclusion Criteria:

          -  (I) Pregnancy or lactation, (II) History of receiving professional periodontal
             treatment during the past 6 months; (III) Treatment with any type of medications and/
             or antibiotics during the past 3 months and (IV) Current or former smokers.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Nayroz Abelfattah Tarrad</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 23, 2019</study_first_submitted>
  <study_first_submitted_qc>May 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2019</study_first_posted>
  <last_update_submitted>June 8, 2019</last_update_submitted>
  <last_update_submitted_qc>June 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fayoum University</investigator_affiliation>
    <investigator_full_name>Nayroz Abdel Fattah Mohamed Tarrad</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <keyword>periodontitis</keyword>
  <keyword>ferritin</keyword>
  <keyword>hepicidin</keyword>
  <keyword>type 2 diabetes mellitus</keyword>
  <keyword>non surgical perioontal therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

